RT Journal Article
T1 Corrigendum to 'First-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus chemotherapy alone (4 cycles) in advanced non-small cell lung cancer: CheckMate 9LA 2-year update': [ESMO Open Volume 6, Issue 5, October 2021, 100273].
A1 Reck, M
A1 Ciuleanu, T-E
A1 Cobo, M
A1 Schenker, M
A1 Zurawski, B
A1 Menezes, J
A1 Richardet, E
A1 Bennouna, J
A1 Felip, E
A1 Juan-Vidal, O
A1 Alexandru, A
A1 Sakai, H
A1 Lingua, A
A1 Reyes, F
A1 Souquet, P-J
A1 De Marchi, P
A1 Martin, C
A1 Pérol, M
A1 Scherpereel, A
A1 Lu, S
A1 Paz-Ares, L
A1 Carbone, D P
A1 Memaj, A
A1 Marimuthu, S
A1 Zhang, X
A1 Tran, P
A1 John, T
YR 2021
FD 2021-12-02
LK https://hdl.handle.net/10668/24575
UL https://hdl.handle.net/10668/24575
LA en
DS RISalud
RD Apr 10, 2025